Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Analysis of HLA-DRB1*1501 in Multiple Sclerosis Patients in Khuzestan Province, Iran

Nooshin Delfan 1 , * , Hamid Galehdari 1 , Sayed Reza Kazeminejad 1 , Mohammad Shafiei 1 , Rezvan Zabihi 1 and Nastaran Majdinasab 2
Authors Information
1 Department of Genetics, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, IR Iran
2 Khuzestan Multiple Sclerosis Society, Rehabilitation Faculty, Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: March 2017, 19 (3); e5647
  • Published Online: March 26, 2017
  • Article Type: Research Article
  • Received: February 7, 2016
  • Revised: October 4, 2016
  • Accepted: March 18, 2017
  • DOI: 10.5812/zjrms.5647

To Cite: Delfan N, Galehdari H, Kazeminejad S R, Shafiei M, Zabihi R, et al. Analysis of HLA-DRB1*1501 in Multiple Sclerosis Patients in Khuzestan Province, Iran, Zahedan J Res Med Sci. 2017 ; 19(3):e5647. doi: 10.5812/zjrms.5647.

Copyright © 2017, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Zabihi R, Galehdari H, Shafiee M, Kazeminejad SR, Alavi SM. Analysis of HLA-DQB1*0602 in Multiple Sclerosis Patients in Khuzestan Province, Iran. Arch Iran Med. 2015; 18(10): 698-702[PubMed]
  • 2. McDonald WI, Halliday AM. Diagnosis and classification of multiple sclerosis. Br Med Bull. 1977; 33(1): 4-9[PubMed]
  • 3. Gajofatto A, Stefani A, Turatti M, Bianchi MR, Lira MG, Moretto G, et al. Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. Eur J Neurol. 2013; 20(4): 697-703[DOI][PubMed]
  • 4. Compston A, Sawcer S. Genetic analysis of multiple sclerosis. Curr Neurol Neurosci Rep. 2002; 2(3): 259-66[PubMed]
  • 5. Ghabaee M, Bayati A, Amri Saroukolaei S, Sahraian MA, Sanaati MH, Karimi P, et al. Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cell Mol Neurobiol. 2009; 29(1): 109-14[DOI][PubMed]
  • 6. Sayad A. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis. Int J Immunogenet. 2014; 41(4): 330-4[DOI][PubMed]
  • 7. Kollaee A, Ghaffarpor M, Ghlichnia HA, Ghaffari SH, Zamani M. The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis. Int J Immunogenet. 2012; 39(5): 414-22[DOI][PubMed]
  • 8. Amirzargar AA, Tabasi A, Khosravi F, Kheradvar A, Rezaei N, Naroueynejad M, et al. Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study. Eur J Neurol. 2005; 12(1): 25-30[DOI][PubMed]
  • 9. Shahbazi M, Roshandel D, Ebadi H, Fathi D, Zamani M, Boghaee M, et al. High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis. Clin Immunol. 2010; 137(1): 134-8[DOI][PubMed]
  • 10. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33(11): 1444-52[PubMed]
  • 11. Ramagopalan SV, Ebers GC. Genes for multiple sclerosis. Lancet. 2008; 371(9609): 283-5[DOI][PubMed]
  • 12. Zephir H, Fajardy I, Outteryck O, Blanc F, Roger N, Fleury M, et al. Is neuromyelitis optica associated with human leukocyte antigen? Mult Scler. 2009; 15(5): 571-9[DOI][PubMed]
  • 13. Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI, et al. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population. J Neurol Sci. 2007; 258(1-2): 69-74[DOI][PubMed]
  • 14. Kouri I, Papakonstantinou S, Bempes V, Vasiliadis HS, Kyritsis AP, Pelidou SH. HLA associations with multiple sclerosis in Greece. J Neurol Sci. 2011; 308(1-2): 28-31[DOI][PubMed]
  • 15. Fernandez O, R. Antiguedad A , Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, et al. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol. 2009; 256(12): 1977-88[DOI][PubMed]
  • 16. Irizar H, Munoz-Culla M, Zuriarrain O, Goyenechea E, Castillo-Trivino T, Prada A, et al. HLA-DRB1*15:01 and multiple sclerosis: a female association? Mult Scler. 2012; 18(5): 569-77[DOI][PubMed]
  • 17. Balnyte R, Rastenyte D, Vaitkus A, Mickeviciene D, Skrodeniene E, Vitkauskiene A, et al. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania. BMC Neurol. 2013; 13: 77[DOI][PubMed]
  • 18. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol. 2000; 48(2): 211-9[PubMed]
  • 19. Kaimen-Maciel DR, Reiche EM, Borelli SD, Morimoto HK, Melo FC, Lopes J, et al. HLA-DRB1* allele-associated genetic susceptibility and protection against multiple sclerosis in Brazilian patients. Mol Med Rep. 2009; 2(6): 993-8[DOI][PubMed]
  • 20. Johnson BA, Wang J, Taylor EM, Caillier SJ, Herbert J, Khan OA, et al. Multiple sclerosis susceptibility alleles in African Americans. Genes Immun. 2010; 11(4): 343-50[DOI][PubMed]
  • 21. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Ornek I, Vaughan R, Eraksoy M. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol. 1997; 55(1): 59-65[PubMed]
  • 22. Kwon OJ, Karni A, Israel S, Brautbar C, Amar A, Meiner Z, et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol. 1999; 56(5): 555-60[PubMed]
  • 23. Floor K. HLA A, B, Cw. DRB1 and DQB1 Alleles in Multiple Sclerosis Patients in India. Int J Hum Genet. 2012; 12(1): 37-40
  • 24. Wu XM, Wang C, Zhang KN, Lin AY, Kira J, Hu GZ, et al. Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations. Mult Scler. 2009; 15(12): 1422-30[DOI][PubMed]
  • 25. Kelly MA, Jacobs KH, Penny MA, Mijovic CH, Nightingale S, Barnett AH, et al. An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro-Caribbean ethnic origin. Tissue Antigens. 1995; 45(3): 197-202[PubMed]
  • 26. Caballero A, Alves-Leon S, Papais-Alvarenga R, Fernandez O, Navarro G, Alonso A. DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. Tissue Antigens. 1999; 54(5): 524-6[PubMed]
  • 27. Alaez C, Corona T, Ruano L, Flores H, Loyola M, Gorodezky C. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans. Acta Neurol Scand. 2005; 112(5): 317-22[DOI][PubMed]
  • 28. Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, et al. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens. 2009; 74(1): 17-21[DOI][PubMed]
  • 29. Sharafaddinzadeh N, Moghtaderi A, Majdinasab N, Dahmardeh M, Kashipazha D, Shalbafan B. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs. Clin Neurol Neurosurg. 2013; 115(8): 1271-5[DOI][PubMed]
  • 30. Najim Al-Din AS, Kurdi A, Mubaidin A, El-Khateeb M, Khalil RW, Wriekat AL. Epidemiology of multiple sclerosis in Arabs in Jordan: a comparative study between Jordanians and Palestinians. J Neurol Sci. 1996; 135(2): 162-7[PubMed]
  • 31. al-Din AS, el-Khateeb M, Kurdi A, Mubaidin A, Wriekat A, al-Shehab A, et al. Multiple sclerosis in Arabs in Jordan. J Neurol Sci. 1995; 131(2): 144-9[PubMed]
  • 32. Benedek G, Paperna T, Avidan N, Lejbkowicz I, Oksenberg JR, Wang J, et al. Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel. Genes Immun. 2010; 11(5): 423-31[DOI][PubMed]
  • 33. Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002; 72(2): 184-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments